{"id":470571,"date":"2025-10-03T07:55:12","date_gmt":"2025-10-03T07:55:12","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/470571\/"},"modified":"2025-10-03T07:55:12","modified_gmt":"2025-10-03T07:55:12","slug":"is-now-a-good-time-to-buy-uk-stocks","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/470571\/","title":{"rendered":"Is Now a Good Time to Buy UK Stocks?"},"content":{"rendered":"<p>Key Takeaways<\/p>\n<ul class=\"mdc-story-list__mdc mdc-story-list--unordered__mdc mdc-story-body__block__mdc\">\n<li>The UK market is still undervalued, despite the FTSE 100\u2019s record climb.<\/li>\n<li>Basic materials stocks are the most attractively valued out of all UK sectors.<\/li>\n<li>UK housing stocks such as Persimmon screen as undervalued.<\/li>\n<\/ul>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">With many global stock markets, including the UK, hitting new records recently, finding quality stocks at a decent price has become a challenge for investors.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">The <a href=\"https:\/\/indexes.morningstar.com\/indexes\/details\/morningstar-uk-FS0000AQFS?currency=GBP&amp;variant=TR&amp;tab=overview\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">Morningstar UK Index<\/a> has returned 18.3% year to date in pounds, marking its best run since 2009, ahead of the US market and level pegging with stocks in the eurozone.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">While this gain has made the UK market\u2019s price\/fair value less attractive than it was three years ago, domestic stocks are still screening as undervalued overall.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">And looking at the relative attractiveness of stock market valuations across regions makes a compelling case for investing in the UK: of the US, UK, and European stock markets, the UK is the most discounted of the three.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">\u201cWe find the UK equity market more attractive than the US market\u2014especially because US valuations are particularly steep at the moment,\u201d says Nicol\u00f2 Bragazza, associate portfolio manager at Morningstar.<\/p>\n<\/p>\n<p>Are UK Stocks Attractively Priced?<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">The UK\u2019s FTSE 100 index hit another record high at the start of Q4, making 2025\u2019s gains the best since 2009 so far. Financials and defense stocks have driven the UK market gains. After a volatile first half of the year, because of the tariff selloff, US markets have regained momentum and found a new leg upwards as the Nvidia-driven AI boom continues.<\/p>\n<p><a href=\"https:\/\/global.morningstar.com\/en-gb\/markets\/whats-outlook-uk-stocks-q4\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc mdc-link--no-underline__mdc mdc-story-interstitial-link__link__mdc\" target=\"_blank\" rel=\"noopener\">What&#8217;s the Outlook for UK Stocks in Q4?<\/a><\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">The recovery in share prices, especially in the US, is visible in the chart above, with a sharp drop in April followed by a sharp, but sustained recovery.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">This move has left US stocks as a whole screening just above 1, meaning they are, on aggregate, overvalued.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">UK stocks, however, currently trade at a more attractive price\/fair value ratio of 0.92. Though this discount is smaller than it was this time a year ago, it allows investors more of a \u201cmargin of safety\u201d, a key tenet of value investing.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">\u201cThe UK is cheaper than the US, but it\u2019s also cheap relative to the rest of Europe,\u201d says Morningstar chief European market strategist Michael Field.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">\u201cThe broader European index is trading at 0.94. The main takeaway from this is that it\u2019s all about relative discounts these days. With the US trading at a slight premium, the UK represents good value at the margin.\u201d<\/p>\n<\/p>\n<p>Which UK Stock Sectors Look Cheap?<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">Within the UK stock market, basic materials, real estate, and healthcare companies are screening as more undervalued than the wider market.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">Out of 11 Morningstar stock sectors, basic materials stocks are the most attractively valued at 0.82 price\/fair value, with UK healthcare and real estate close behind at 0.85.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">As the table below shows, these three sectors are the fourth, seventh and ninth-best performing sectors of 11 peers since the start of the year. Basic materials stocks have returned 14.12%, with healthcare lagging behind on 7.13%, and real estate on 2.70%.<\/p>\n<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">In the basic materials sector, mining giant Glencore <a href=\"https:\/\/global.morningstar.com\/en-gb\/investments\/stocks\/0P0000T29L\/quote\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">GLEN<\/a> appears among the most attractively valued, with a price\/fair value ratio of 0.72 and a 4-star Morningstar rating, indicating it is undervalued by the market.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">Sector peer Rio Tinto <a href=\"https:\/\/global.morningstar.com\/en-gb\/investments\/stocks\/0P00007OTS\/quote\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">RIO<\/a> also has a 0.72 price\/fair value and a 4-star Morningstar rating. Both stocks have enjoyed lackluster share price performance, with Rio Tinto up just 3% during 2025 and Glencore down 8% over the same period. This is against an 18% rise in the <a href=\"https:\/\/indexes.morningstar.com\/indexes\/details\/morningstar-uk-FS0000AQFS?currency=GBP&amp;variant=TR&amp;tab=overview\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">Morningstar UK Index <\/a>so far this year.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">Rio can still close this valuation gap, Morningstar equity analyst Jon Mills said in a July note.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">\u201cRio Tinto has low operating costs and a strong balance sheet, with capital allocation significantly improved following a period of overinvestment through the China commodities boom.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">\u201cHowever, it still faces the cyclicality of commodity prices, operating leverage, high capital intensity, and the risk of poor capital allocation.\u201d<\/p>\n<\/p>\n<p>Are UK Housing Stocks a Buy?<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">Real estate stocks also appear cheaper than the overall UK market. An important contributor to the health of the UK economy, housebuilders have had a rough time after fresh promises of housing expansion by the new Labour government last year gave way to pessimism about the slow speed of interest rate cuts. <a href=\"https:\/\/global.morningstar.com\/en-gb\/economy\/is-uk-economy-heading-recession-heres-what-key-economic-indicators-say\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">Declining consumer confidence<\/a> and prohibitive stamp duty increases have also poured water on recovery hopes. Those looking to buy or sell a property will also be anxiously awaiting the Autumn Budget in November, <a href=\"https:\/\/global.morningstar.com\/en-gb\/economy\/rachel-reeves-autumn-budget-what-higher-taxes-could-mean-you\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">where proposed changes to the tax treatment of the sector are under consideration<\/a>.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">Key stocks Persimmon <a href=\"https:\/\/global.morningstar.com\/en-gb\/investments\/stocks\/0P00007OQH\/quote\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">PSN<\/a>, Barratt Redrow <a href=\"https:\/\/global.morningstar.com\/en-gb\/investments\/stocks\/0P00007NZR\/quote\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">BTRW<\/a>, and Taylor Wimpey <a href=\"https:\/\/global.morningstar.com\/en-gb\/investments\/stocks\/0P00007OYA\/quote\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">TW.<\/a> are all significantly undervalued. Overall, UK real estate companies are trading at around 0.85 price\/fair value\u2014a greater discount than the broader market. Investors will have to wait for the <a href=\"https:\/\/global.morningstar.com\/en-gb\/economy\/rachel-reeves-autumn-budget-what-higher-taxes-could-mean-you\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">Autumn Budget on Nov. 26<\/a> to see whether there are any housing policies conducive to a more supportive environment for stocks.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\"><a href=\"https:\/\/global.morningstar.com\/en-gb\/stocks\/ahead-autumn-budget-uk-housebuilding-stocks-look-attractive\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">In a recent report on UK homebuilders<\/a>, Morningstar analyst Jack Fletcher-Price noted the depressed sector valuations, even after fair value estimates were cut in the summer.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">\u201cWe lowered our fair value estimates for all homebuilders in the second quarter of 2025 after moderating our near- and medium-term expectations for house price growth and margin recovery, but they continue to screen attractively,\u201d he said in September.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">\u201cShares had performed reasonably well year-to-date, before the sector sold off once more as rate cut expectations were pared back and government bond yields rose.\u201d<\/p>\n<\/p>\n<p>UK Healthcare Stocks in Focus<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">Among the UK\u2019s discounted sectors, healthcare stocks are likewise attractively priced. Among the most attractive is GSK <a href=\"https:\/\/global.morningstar.com\/en-gb\/investments\/stocks\/0P00007OD0\/quote\" tabindex=\"0\" class=\"mdc-link__mdc mdc-link--body__mdc\" target=\"_blank\" rel=\"noopener\">GSK<\/a>, the British pharmaceutical manufacturer and research giant.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">Morningstar senior equity analyst Jay Lee says the company\u2019s broad range of innovative products help earn it a wide economic moat, suggesting it will be able to fend off competition in the healthcare sector for years\u2014and potentially decades\u2014to come. Its decision to divest of consumer business Haleon in 2022 also looks like a good long-term call, he says. The company has recently announced that chief executive Emma Walmsley will step down at the end of this year.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">\u201cGSK has shifted from its historical strategy of targeting slight enhancements toward true innovation,\u201d Lee says.<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">\u201cAlso, it is focusing more on oncology and immunology, with genetic data to help develop the next generation of drugs. The benefits of these strategies are showing up in GSK\u2019s early-stage drugs. We expect this focus will improve approval rates and pricing power. In contrast to respiratory drugs, treatments for cancer indications carry much stronger pricing power with payers.\u201d<\/p>\n<p class=\"mdc-story-body__paragraph__mdc mdc-story-body__paragraph--large__mdc mdc-story-body__block__mdc\">James Gard contributed to this story<\/p>\n<p>The author or authors do not own shares in any securities mentioned in this article. Find out about <a href=\"https:\/\/global.morningstar.com\/en-gb\/policies\/morningstars-editorial-policies\" tabindex=\"0\" target=\"_blank\" class=\"mdc-link__mdc mdc-link--body__mdc\" rel=\"noopener\"><br \/>\n\t\t\t\t\t\t\t\t\tMorningstar&#8217;s editorial policies.<br \/>\n\t\t\t\t\t\t\t\t<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Key Takeaways The UK market is still undervalued, despite the FTSE 100\u2019s record climb. Basic materials stocks are&hellip;\n","protected":false},"author":2,"featured_media":470572,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3091],"tags":[51,2441,16,15],"class_list":{"0":"post-470571","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-markets","8":"tag-business","9":"tag-markets","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115309164976911806","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/470571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=470571"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/470571\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/470572"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=470571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=470571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=470571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}